» Articles » PMID: 34502448

Molecular Network Approach Reveals As a Central Target of Cardiac ProtectomiRs

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Sep 10
PMID 34502448
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Cardioprotective medications are still unmet clinical needs. We have previously identified several cardioprotective microRNAs (termed ProtectomiRs), the mRNA targets of which may reveal new drug targets for cardioprotection. Here we aimed to identify key molecular targets of ProtectomiRs and confirm their association with cardioprotection in a translational pig model of acute myocardial infarction (AMI). By using a network theoretical approach, we identified 882 potential target genes of 18 previously identified protectomiRs. The gene was the most central and it was ranked first in the protectomiR-target mRNA molecular network with the highest node degree of 5. Therefore, and its targeting microRNAs were further validated in heart samples obtained from a translational pig model of AMI and cardioprotection induced by pre- or postconditioning. Three out of five -targeting pig homologue of rat ProtectomiRs showed significant upregulation in postconditioned but not in preconditioned pig hearts. was downregulated at the mRNA and protein level in ischemic postconditioning but not in ischemic preconditioning. This is the first demonstration that is the central molecular target of ProtectomiRs and that decreased expression may regulate ischemic postconditioning-, but not preconditioning-induced acute cardioprotection. We conclude that is a potential novel drug target for acute cardioprotection.

Citing Articles

MINOCA: A Pathophysiological Approach of Diagnosis and Treatment-A Narrative Review.

Khattab E, Karelas D, Pallas T, Kostakis P, Papadopoulos C, Sideris S Biomedicines. 2024; 12(11).

PMID: 39595023 PMC: 11592352. DOI: 10.3390/biomedicines12112457.


Whole-genome sequencing reveals genetic structure and adaptive genes in Nepalese buffalo breeds.

Dhakal A, Si J, Sapkota S, Pauciullo A, Han J, Gorkhali N BMC Genomics. 2024; 25(1):1082.

PMID: 39543523 PMC: 11566569. DOI: 10.1186/s12864-024-10993-w.


Identification of New, Translatable ProtectomiRs against Myocardial Ischemia/Reperfusion Injury and Oxidative Stress: The Role of MMP/Biglycan Signaling Pathways.

Szabados T, Molnar A, Kenyeres E, Gomori K, Pipis J, Posa B Antioxidants (Basel). 2024; 13(6).

PMID: 38929113 PMC: 11201193. DOI: 10.3390/antiox13060674.


YB-1 Is a Novel Target for the Inhibition of α-Adrenergic-Induced Hypertrophy.

Heger J, Partsch S, Harjung C, Varga Z, Baranyai T, Weiss J Int J Mol Sci. 2024; 25(1).

PMID: 38203580 PMC: 10778708. DOI: 10.3390/ijms25010401.


Pressure overload-induced systolic heart failure is associated with characteristic myocardial microRNA expression signature and post-transcriptional gene regulation in male rats.

Ruppert M, Korkmaz-Icoz S, Benczik B, Agg B, Nagy D, Balint T Sci Rep. 2023; 13(1):16122.

PMID: 37752166 PMC: 10522609. DOI: 10.1038/s41598-023-43171-1.


References
1.
Shende P, Xu L, Morandi C, Pentassuglia L, Heim P, Lebboukh S . Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy. Cardiovasc Res. 2015; 109(1):103-14. DOI: 10.1093/cvr/cvv252. View

2.
Martin J, Masri J, Bernath A, Nishimura R, Gera J . Hsp70 associates with Rictor and is required for mTORC2 formation and activity. Biochem Biophys Res Commun. 2008; 372(4):578-83. PMC: 2512964. DOI: 10.1016/j.bbrc.2008.05.086. View

3.
Wong N, Wang X . miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 2014; 43(Database issue):D146-52. PMC: 4383922. DOI: 10.1093/nar/gku1104. View

4.
Varga Z, Zvara A, Farago N, Kocsis G, Pipicz M, Gaspar R . MicroRNAs associated with ischemia-reperfusion injury and cardioprotection by ischemic pre- and postconditioning: protectomiRs. Am J Physiol Heart Circ Physiol. 2014; 307(2):H216-27. DOI: 10.1152/ajpheart.00812.2013. View

5.
Ferdinandy P, Hausenloy D, Heusch G, Baxter G, Schulz R . Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev. 2014; 66(4):1142-74. DOI: 10.1124/pr.113.008300. View